This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
New Name. Same Power. Lidex (fluocinonid) × 0.05% y Brief Summary of Prescribing Information LIDEX® (fluocinonide) Gel 0.05% Description: LIDEX gel 0.05% is intended for topical administration. The active component is the corticosteroid fluocinonide, which is the 21-acetate ester of fluocinolone acetonide and has the chemical name pregna-1,4-diene-3,20-dione,21-(acetyloxy)-6,9-difluoro-11 -hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6α,11β,16α)LIDEX gel contains fluocinonide 0.5 mg/g in a specially formulated gel base consisting of propylene glycol, propyl gallate, edetate disodium, and carbomer 940, with NaOH and/or HCl added to adjust the pH. This clear, colorless thixotropic vehicle is greaseless, non-staining and completely water miscible In this formulation, the active ingredient is totally in solution. Indications: Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses Contraindications: Hypersensitivity to any ingredient. Precautions General Periodically evaluate patients given a large dose of a potent topical steroid applied to a large area or under occlusive dressing for HPA suppression by using urinary free cortisol and
News and Notes. Arch Dermatol. 1985;121(1):34. doi:10.1001/archderm.1985.01660010038015